tetano
Editor, Senior Moderator
Vaccines (Basel)
. 2022 Sep 29;10(10):1638.
doi: 10.3390/vaccines10101638.
The Antibody Response to the BNT162b2 mRNA COVID-19 Booster in Healthcare Workers: Association between the IgG Antibody Titers and Anthropometric and Body Composition Parameters
Marlena Golec[SUP] 1 [/SUP], Adam Konka[SUP] 1 [/SUP], Martyna Fronczek[SUP] 1 2 [/SUP], Joanna Zembala-John[SUP] 1 3 4 [/SUP], Martyna Chrapiec[SUP] 1 [/SUP], Karolina Wystyrk[SUP] 1 [/SUP], Sławomir Kasperczyk[SUP] 5 [/SUP], Zenon Brzoza[SUP] 6 [/SUP], Rafał Jakub Bułdak[SUP] 1 7 [/SUP]
Affiliations
Abstract
Background: Research shows that in most people, two-dose vaccination helps to shape the humoral response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Further studies are required to learn about the vaccine's effectiveness after boosting.
Methods: We conducted a prospective study among 103 healthcare workers (HCWs) from a regional multi-specialty hospital vaccinated with three doses of the BNT162b2 vaccine. We compared their immunoglobulin G (IgG) titers 14 days after the second dose with those 21 days after the booster. We also compared their anthropometric and body composition parameters with IgG concentrations at the same time points.
Results: Twenty-one days after the booster, all study participants were seropositive. Their mean IgG antibody titers were significantly lower than 14 days after the second dose (158.94 AU/mL ± 90.34 AU/mL vs. 505.79 AU/mL ± 367.16 AU/mL). Post-booster Spearman's correlation analysis showed a significantly weak correlation between the IgG antibody titer and parameters related to muscle tissue and adipose tissue (including body fat mass).
Conclusions: The BNT162b2 booster stimulates the humoral response to a lesser extent than the two-dose BNT162b2 primary vaccination. The adipose and muscle tissue parameters show a weak positive correlation with the SARS-CoV-2 IgG antibody titers.
Keywords: BNT162b2 vaccine; COVID-19; COVID-19 vaccine; IgG antibody; SARS-CoV-2; body composition; booster; healthcare workers; humoral response; immunization.
. 2022 Sep 29;10(10):1638.
doi: 10.3390/vaccines10101638.
The Antibody Response to the BNT162b2 mRNA COVID-19 Booster in Healthcare Workers: Association between the IgG Antibody Titers and Anthropometric and Body Composition Parameters
Marlena Golec[SUP] 1 [/SUP], Adam Konka[SUP] 1 [/SUP], Martyna Fronczek[SUP] 1 2 [/SUP], Joanna Zembala-John[SUP] 1 3 4 [/SUP], Martyna Chrapiec[SUP] 1 [/SUP], Karolina Wystyrk[SUP] 1 [/SUP], Sławomir Kasperczyk[SUP] 5 [/SUP], Zenon Brzoza[SUP] 6 [/SUP], Rafał Jakub Bułdak[SUP] 1 7 [/SUP]
Affiliations
- PMID: 36298503
- DOI: 10.3390/vaccines10101638
Abstract
Background: Research shows that in most people, two-dose vaccination helps to shape the humoral response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Further studies are required to learn about the vaccine's effectiveness after boosting.
Methods: We conducted a prospective study among 103 healthcare workers (HCWs) from a regional multi-specialty hospital vaccinated with three doses of the BNT162b2 vaccine. We compared their immunoglobulin G (IgG) titers 14 days after the second dose with those 21 days after the booster. We also compared their anthropometric and body composition parameters with IgG concentrations at the same time points.
Results: Twenty-one days after the booster, all study participants were seropositive. Their mean IgG antibody titers were significantly lower than 14 days after the second dose (158.94 AU/mL ± 90.34 AU/mL vs. 505.79 AU/mL ± 367.16 AU/mL). Post-booster Spearman's correlation analysis showed a significantly weak correlation between the IgG antibody titer and parameters related to muscle tissue and adipose tissue (including body fat mass).
Conclusions: The BNT162b2 booster stimulates the humoral response to a lesser extent than the two-dose BNT162b2 primary vaccination. The adipose and muscle tissue parameters show a weak positive correlation with the SARS-CoV-2 IgG antibody titers.
Keywords: BNT162b2 vaccine; COVID-19; COVID-19 vaccine; IgG antibody; SARS-CoV-2; body composition; booster; healthcare workers; humoral response; immunization.